Another new report confirms small excess risk of GLP-1 drugs for NAION, a vision-threatening condition (acronym for nonarteritic anterior ischemic optic neuropathy) acpjournals.org/doi/epdf/10.73 Another new report confirms small excess risk of GLP-1 drugs for NAION, a vision-threatening condition (acronym for nonarteritic anterior ischemic optic neuropathy) acpjournals.org/doi/epdf/10.73 Thanks @EricTopol
Overweight and obesity have been linked to at least 13 types of cancer
[DOI] [PMC free article] [PubMed] [Google Scholar] 128.Gorgojo-Martinez J.J., Mezquita-Raya P., Carretero-Gomez J., Castro A., Cebrian-Cuenca A., de Torres-Sanchez A., et al
Copyright The Nations Health, American Public Health Association
These effects typically resolve with continued treatment and are generally manageable within established GLP-1 agonist safety protocols
Why does Brecka emphasize methylation